Clinical correlation between dyslipidemia and pediatric chronic allograft nephropathy

Pediatric Transplantation

Volumn 12, Issue 7, 2008, Pages 748-754

  Valavi, Ehsan ^a   Otukesh, Hasan ^b   Fereshtehnejad, Seyed Mohammad ^b   Sharifian, Mostapha ^c  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic allograft nephropathy; Dyslipidemia

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CHRONIC ALLOGRAFT NEPHROPATHY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY FUNCTION TEST; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, LDL; CHRONIC DISEASE; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 53949103542     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.00981.x     Document Type: Article

References (29)

1. Stephen I, Jeffrey A, Fletcher T, Nankivell BJ. Chronic allograft nephropathy in paediatric renal transplantation. Pediatr Nephrol 2007 : 22 : 17 23.
2. Hostetter TH. Chronic transplant rejection. Kidney Int 1994 : 46 : 266 279.
3. Carpenter CB. Long term failure of renal transplants. Kidney Int 1995 : 48 : 40.
4. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995 : 59 : 313 318.
5. Noris M, Mister M, Pezzotta A, et al. ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established. Kidney Int 2003 : 64 : 2253.
6. Krieger NR, Becker BN, Heisey DM, et al. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation 2003 : 75 : 1677.
7. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005 : 16 : 3015.
8. Massy ZA, Guijarro C, Wiederkehr MR, Ma JZ, Kasiske BL. Chronic renal allograft rejection: Immunologic and nonimmunologic risk factors. Kidney Int 1996 : 49 : 518.
9. Guijarro C, Massy ZA, Kasiske BL. Clinical correlation between renal allograft failure and hyperlipidemia. Kidney Int Suppl 1995 : 52 : 556.
10. Katznelson S, Wilkinson AH, Kobashigowa JA, et al. The effect of pravastatin on acute rejection after kidney transplantation. Transplantation 1996 : 61 : 1469.
11. Ponticelli C, Villa M, Cesana B, Montagnino G, Tarantino A. Risk factors for late kidney allograft failure. Kidney Int 2002 : 62 : 1848.
12. NIH. Lipid Research Clinics Population Studies Data Book. Vol 1 : The Prevalence Study. NIH Publication No. 80-1527. Washington, DC : National Institutes of Health, 1980.
13. Hickman TB, Brief RR, Carroll MD, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: Data from the Third National Health and Nutrition Examination Survey. Prev Med 1998 : 27 : 879 890.
14. Kasiske BL, Cosio FG, Beto J, et al. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: A report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 2004 : 7 : 13.
15. Aakhus S, Dahl K, Wideroe TE. Hyperlipidemia in renal transplant patients. J Intern Med 1996 : 239 : 407.
16. Brown JH, Murphy BG, Douglas AF, et al. Influence of immunosuppressive therapy on lipoprotein (a) and other lipoproteins following renal transplantation. Nephron 1997 : 75 : 277.
17. Gonyea JE, Anderson CF. Weight change and serum lipoproteins in recipients of renal allografts. Mayo Clin Proc 1992 : 67 : 653.
18. Moore R, Thomas D, Morgan E, et al. Abnormal lipid and lipoprotein profiles following renal transplantation. Transplant Proc 1993 : 25 : 1060.
19. Massy ZA, Kasiske BL. Post-transplant hyperlipidemia: Mechanisms and management. J Am Soc Nephrol 1996 : 7 : 971.
20. Kasiske BL, Tortorice KL, Heim-Duthoy KL. The adverse impact of cyclosporine on serum lipids in renal transplant recipients. Am J Kidney Dis 1991 : 17 : 700.
21. Vathsala A, Weinberg RB, Kahan BD. Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients. Transplantation 1989 : 48 : 37.
22. Ingulli E, Tejani A. Severe hypercholesterolemia inhibits cyclosporin A efficacy in a dose-dependent manner in children with nephrotic syndrome. J Am Soc Nephrol 1992 : 3 : 254.
23. Dimeny E, Fellstrom B, Larsson E, et al. Chronic vascular rejection and hyperlipoproteinemia in renal transplant recipients. Clin Transplant 1993 : 7 : 482.
24. Sahin S, Manga Sahin G, Kantarci G, Ergin H, Sezgin O. Lipid profile in chronic allograft nephropathy. Transplant Proc 2006 : 38 : 477 479.
25. Keane WF, Mulcahy WS, Kasiske BL, et al. Hyperlipidemia and progressive renal disease. Kidney Int 1991 : 36 : 41 48.
26. Kipar T, Hughes J. Macrophage mediated renal cell death. Kidney Int 2002 : 61 : 760 761.
27. Moreso F, Lopez M, Vallejos A, et al. Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts. Am J Transplant 2001 : 1 : 82 88.
28. de Vries AP, Bakker SJ, Van Son WJ, et al. Metabolic syndrome is associated with impaired long term renal allograft function; not all component criteria contribute equally. Am J Transplant 2004 : 4 : 1675.
29. Bosmans JL, Holvoet P, Dauwe SE. Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years. Kidney Int 2001 : 59 : 2346 2356.